Abstract:Among the various drug induced dermatological entities toxic epidermalnecrolysis (TEN) and Stevens-Johnson syndrome (SJS) occupy a primary place in terms of mortality. Toxic epidermal necrolysis also known as Lyell's syndrome was first described by Lyell in 1956. Drugs are by far the most common cause of toxic epidermal necrolysis, in which large sheets of skin are lost from the body surface making redundant the barrier function of the skin, with its resultant complications. Drug-induced toxic epidermal necrolysis are severe adverse cutaneous drug reactions to various precipitating agents that predominantly involve the skin and mucous membranes. Toxic epidermal necrolysis is rare but considered medical emergencies as they are potentially fatal. Drugs are the most common cause accounting for about 65%-80% of the cases. The most common offending agents are sulfonamides, NSAIDs, butazones and hydrantoins. An immune mechanism is implicated in the pathogenesis, but its nature is still unclear. There is a prodormal phase in which there is burning sensation all over the skin and conjunctivae, along with skin tenderness, fever, malaise and arthralgias. Early sites of cutaneous involvement are the presternal region of the trunk and the face, but also the palms and soles, rapidly spread to their maximum extent, the oral mucosa and conjunctiva being affected. Initial lesions are macular, followed by desquamateion, or may be from atypical targets with purpuriccenters that coalesce, from bullae, then slough. The earlier a causative agent is withdrawn the better is the prognosis. Several treatment modalities given in addition to supportive care are reported in the literature, such as systemicsteroids, high-dose intravenous immunoglobulins, ciclosporin, TNF antagonists. Recovery is slow over a period of 14-28 days and relapses are frequent. Mortality is 25%-50% and half the deaths occur due to secondary infection. Here we report a 50-year-old female of drug-induced toxic epidermal necrolysis. She was admitted to the dermatology ward with extensive peeling of skin over the trunk and limbs. She had taken alamotrigine for epilepsy. A week after taking the tablets, the patient developed a severe burning sensation all over the body and followed by a polymorphic erythematous dermatitis and widespread peeling of skin. We treated this patient with high dose corticosteroids, high-dose intravenous immunoglobulins and etanercept, but eventually she died of secondary aspergillus fumigatus infection.

A Case Report of Xuesaitong-induced Severe drug eruption

A Case of Drug Hypersensitivity Syndrome Caused by Allopurinol

Drug-induced Exfoliative Dermatitis: Literature Analysis of 240 Cases

A Case of Bullous Eosinophilic Cellulitis

Drug-induced Erythroderma in Patients with Acquired Immunodeficiency Syndrome.

[Clinical Characteristics and Prognosis for 126 Patients with Severe Drug Eruption].

Analysis of 33 Cases of Aged People With Severe Drug Eruption

A Case of Generalized Fixed Drug Eruption Induced by Allopurinol and Hydroxyurea

Analysis of 112 Cases of Severe Drug Eruption

Retrospective Study with 44 Cases with Severe Drug Eruptions

Purulent Bullous Epidermal Necrolysis: A Potential New Clinical Pattern of Drug Eruption

Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine

The clinical analysis of 73 cases with severe drug eruption

Clinical Analysis of 16 Patients with Bullous Epidermolysis Type of Drug Eruption

Drug-induced Toxic Epidermal Necrolysis with Secondary Aspergillus Fumigatus Infection: a Case Report

Case report: Drug rash with eosinophilia and systemic symptoms syndrome in a patient with anti-interferon-γ autoantibody-associated immunodeficiency

Vitiligo‐like Depigmentation Associated with Xuesaitong Capsule Treatment

Severe Contact Dermatitis and Systemic Reaction Caused by Fresh Clematis Chinensis Osbeck:A Case Report

A unique case of bullous drug eruption related to vancomycin and cefoperazone

One case of exfoliative dermatitis induced by sulbenicillin for injection

Analysis on Causative Drugs of 1883 Drug Eruptions in a Hospitalized Population